CG Oncology
CGON
CGON
193 hedge funds and large institutions have $3.43B invested in CG Oncology in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 72 increasing their positions, 50 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $3.13B → $3.43B (+$303M)
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
0.6% more ownership
Funds ownership: 101.84% → 102.44% (+0.6%)
Holders
193
Holding in Top 10
13
Calls
$74M
Puts
$29.6M
Top Buyers
| 1 | +$76.7M | |
| 2 | +$39.3M | |
| 3 | +$31.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.3M |
Top Sellers
| 1 | -$58.5M | |
| 2 | -$56.8M | |
| 3 | -$43.8M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$27.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$25.2M |
